Skip to main content
XWEL
NASDAQ Trade & Services

XWELL Finalizes $31.3M Deeply Discounted Private Placement, Issuing Highly Dilutive Preferred Stock and Warrants

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.38
Mkt Cap
$7.785M
52W Low
$0.255
52W High
$2.2
52W Position info
441% above low
Off High info
37% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

XWEL has more than doubled off its 52-week low of $0.255 on light trading volume (0.1× avg).

Summary

XWELL, Inc. announced the closing of its previously reported $31.3 million private placement, issuing Series H Convertible Preferred Stock and warrants at deeply discounted prices, which will result in substantial dilution.


Key Events · Financing and Capital Events · XWEL

  • Private Placement Closes

    XWELL, Inc. completed its private placement, raising aggregate gross proceeds of $31,333,000 through the issuance of Series H Convertible Preferred Stock and warrants.

  • Highly Dilutive Securities Issued

    The company issued 31,333 shares of Series H Preferred Stock, convertible into up to 66,665,957 common shares at $0.47 per share, and warrants to purchase up to 66,665,957 common shares at an exercise price of $0.345 per share. An additional 5,333,277 warrants were issued to the placement agent.

  • Repurchase of Prior Preferred Stock and Notes

    The company used $9,000,000 from the private placement proceeds to repurchase all outstanding Series G Preferred Stock and related senior secured convertible notes.

  • Elimination of Series G Preferred Stock

    A Certificate of Elimination was filed for the Series G Convertible Preferred Stock, removing its designation and returning the shares to authorized but unissued status.


Analysis · XWEL · Trade & Services

XWELL, Inc. has completed its previously announced private placement, securing $31.3 million in gross proceeds. This capital raise is substantial for the company, providing critical funding. However, the terms are highly dilutive, involving the issuance of Series H Convertible Preferred Stock convertible at $0.47 per share and warrants exercisable at $0.345 per share, both significantly below the current stock price of $1.38. The transaction also includes warrants for the placement agent. The aggregate potential issuance of over 138 million new shares represents a massive dilution to existing shareholders. A portion of the proceeds, $9 million, was used to repurchase outstanding Series G Preferred Stock and related notes, which helps clean up the balance sheet but underscores the high cost of this new capital.

At the time of this filing, XWEL was trading at $1.38 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $7.8M. The 52-week trading range was $0.26 to $2.20. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XWEL - Latest Insights

XWEL
Jul 24, 2026, 5:39 PM EDT
Filing Type: PREM14A
Importance Score:
8
Price at Filing: $1.05
Real-time Price: $1.08 info
Change: +$0.0296 (+3%) info
Market Cap: $8.866M info
XWEL
Jul 09, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.996
Real-time Price: $1.08 info
Change: +$0.0836 (+8%) info
Market Cap: $8.866M info
XWEL
May 20, 2026, 4:11 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.46
Real-time Price: $1.08 info
Change: -$0.3804 (-26%) info
Market Cap: $8.866M info
XWEL
May 20, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.46
Real-time Price: $1.08 info
Change: -$0.3804 (-26%) info
Market Cap: $8.866M info
XWEL
Apr 16, 2026, 4:05 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $1.03
Real-time Price: $1.08 info
Change: +$0.0459 (+4%) info
Market Cap: $8.866M info